相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
Amanda L. Huff et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?
Jiajie Hou et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Bacillus Calmette-Guerin Vaccine and Nonspecific Immunity
Kanak Parmar et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2021)
First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations
Linlin Guo et al.
BRITISH JOURNAL OF CANCER (2021)
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
Peter Lawrence Smith et al.
VACCINES (2021)
Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response
Davis W. Crews et al.
FRONTIERS IN ONCOLOGY (2021)
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners
Marek Z. Wojtukiewicz et al.
CANCER AND METASTASIS REVIEWS (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer
Anita K. Mehta et al.
NATURE CANCER (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Re-polarization of immunosuppressive macrophages to tumor-cytotoxic macrophages by repurposed metabolic drugs
Cesar Oyarce et al.
ONCOIMMUNOLOGY (2021)
Review of talimogene laherparepvec: A first-in-class oncolytic viral treatment of advanced melanoma
Karyn Haitz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Cancer immunotherapy: Pros, cons and beyond
Shuzhen Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect
Jiansong Han et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Therapeutic Vaccines and Cancer Immunotherapy
Darshak Bhatt et al.
VACCINES (2020)
Vaccine-Induced CD8+ T Cell Responses in Children: A Review of Age-Specific Molecular Determinants Contributing to Antigen Cross-Presentation
Elisabeth M. S. Beijnen et al.
FRONTIERS IN IMMUNOLOGY (2020)
A Highlight of the Mechanisms of Immune Checkpoint Blocker Resistance
Qian Huang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
BCG as a Vector for Novel Recombinant Vaccines against Infectious Diseases and Cancers
Abu Salim Mustafa
VACCINES (2020)
Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
James L. Gulley et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate Tumors
Patrick A. Ott et al.
CANCER DISCOVERY (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Cancer Vaccines
Peter J. DeMaria et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2019)
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Alessandra Lopes et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Treatment of Metastatic Disease through Natural Killer Cell Modulation by Infected Cell Vaccines
Seyedeh Raheleh Niavarani et al.
VIRUSES-BASEL (2019)
Talimogene laherparepvec: review of its mechanism of action and clinical efficacy and safety
Steven S. Raman et al.
IMMUNOTHERAPY (2019)
Cancer Vaccines: Research and Applications
Vasso Apostolopoulos
CANCERS (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment
Lea Monteran et al.
FRONTIERS IN IMMUNOLOGY (2019)
Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
Jing Zhao et al.
FRONTIERS IN PHARMACOLOGY (2019)
Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers
Jitwadee Inthagard et al.
CLINICAL SCIENCE (2019)
Adoptive cellular therapies: the current landscape
Maartje W. Rohaan et al.
VIRCHOWS ARCHIV (2019)
Factors Associated With Use of Sipuleucel-T to Treat Patients With Advanced Prostate Cancer
Megan E. V. Caram et al.
JAMA NETWORK OPEN (2019)
Oxidative damage and response to Bacillus Calmette-Guerin in bladder cancer cells expressing sialyltransferase ST3GAL1
Paulo F. Severino et al.
BMC CANCER (2018)
Present status and future perspective of peptide-based vaccine therapy for urological cancer
Wataru Obara et al.
CANCER SCIENCE (2018)
Cancer vaccines: translation from mice to human clinical trials
Hoyoung Maeng et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
Catherine E. Handy et al.
FUTURE ONCOLOGY (2018)
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
Janos L. Tanyi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Immunotherapies: Exploiting the Immune System for Cancer Treatment
Jeffrey Koury et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Remy Thomas et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combining Adoptive Cell therapy with Cytomegalovirus-Based Vaccine Is Protective against Solid skin Tumors
Jeremy M. Grenier et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
Franz L. Ricklefs et al.
SCIENCE ADVANCES (2018)
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei et al.
CANCER DISCOVERY (2018)
Personalized cancer neoantigen vaccines come of age
Yanhong Chu et al.
THERANOSTICS (2018)
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo Gonzalez et al.
GENES & DEVELOPMENT (2018)
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
Sandra Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
Ren-You Pan et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
An introduction to immunology and immunopathology
Jean S. Marshall et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
Recent updates on cancer immunotherapy
Ming Liu et al.
PRECISION CLINICAL MEDICINE (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Next Generation Cancer Vaccines-Make It Personal!
Angelika Terbuch et al.
VACCINES (2018)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations
Margaret E. Gatti-Mays et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Peptide vaccines in cancer - old concept revisited
Takumi Kumai et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
Frederick J. Kohlhapp et al.
CLINICAL CANCER RESEARCH (2016)
Pancreatic cancer: Update on immunotherapies and algenpantucel-L
Kinsey A. McCormick et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie de Charette et al.
EUROPEAN JOURNAL OF CANCER (2016)
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers
Claud Grigg et al.
SEMINARS IN ONCOLOGY (2016)
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8(+) and CD4(+) T-cell responses with multiple specificities including a novel DR7-restricted epitope
P. Baumgaertner et al.
ONCOIMMUNOLOGY (2016)
Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome
Debraj GuhaThakurta et al.
CLINICAL CANCER RESEARCH (2015)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
NK cell-based cancer immunotherapy: from basic biology to clinical application
Li Yang et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Dass S. Vinay et al.
SEMINARS IN CANCER BIOLOGY (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Cancer vaccines
Lisa H. Butterfield
BMJ-BRITISH MEDICAL JOURNAL (2015)
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Ignacio Melero et al.
NATURE REVIEWS CANCER (2015)
Vaccines Through Centuries: Major Cornerstones of Global Health
Inaya Hajj Hussein et al.
FRONTIERS IN PUBLIC HEALTH (2015)
The Promise of Preventive Cancer Vaccines
Pier-Luigi Lollini et al.
VACCINES (2015)
Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer
Lawrence Fong et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
History of vaccination
Stanley Plotkin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi et al.
ONCOTARGET (2014)
Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review
Daniel M. Geynisman et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
Athalia R. Pyzer et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
James L. Gulley et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Live-attenuated bacteria as a cancer vaccine vector
Bertrand Toussaint et al.
EXPERT REVIEW OF VACCINES (2013)
Deciphering and Reversing Tumor Immune Suppression
Greg T. Motz et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study
Jeffrey M. Hardacre et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Richard A. Morgan et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
Ravi A. Madan et al.
LANCET ONCOLOGY (2012)
Whole Cell Vaccines-Past Progress and Future Strategies
Bridget P. Keenan et al.
SEMINARS IN ONCOLOGY (2012)
Viral Vector-Based Therapeutic Cancer Vaccines
Cecilia Larocca et al.
CANCER JOURNAL (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment
Thais Helena Gasparoto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Innate immunity
Stuart E. Turvey et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Adaptive immunity
Francisco A. Bonilla et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Overview of the immune response
David D. Chaplin
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination
Viggo F. Van Tendeloo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MAGE A3 antigen-specific cancer immunotherapeutic
Nir Peled et al.
IMMUNOTHERAPY (2009)
Vaccines: past, present and future
SA Plotkin
NATURE MEDICINE (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials
RJ Sylvester et al.
JOURNAL OF UROLOGY (2002)
Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor
M Toda et al.
MOLECULAR THERAPY (2000)
分享论文
